CPT Code 52204: Cystourethroscopy with Biopsy Billing Guide for 2026

QUICK ANSWER

• What is CPT code 52204? CPT code 52204 is the Current Procedural Terminology code for cystourethroscopy with biopsy. It reports an endoscopic examination of the bladder and urethra combined with one or more tissue biopsies sent to pathology. The code is billed once per session regardless of how many specimens are collected, and it includes the diagnostic cystoscopy component, which means CPT 52000 cannot be reported alongside it for the same encounter.
• Bundling with 52000: CPT 52204 includes the diagnostic cystourethroscopy. Under NCCI edits, 52000 is bundled into 52204 and cannot be billed separately for the same session. Submitting both codes triggers an automatic denial.
• 2026 Medicare reimbursement: The 2026 Medicare Physician Fee Schedule pays $355.39 (non-facility/office) and $126.92 (facility) at the national unadjusted rate, before geographic GPCI adjustment. Commercial payers set their own rates and may pay above or below Medicare.
• Documentation requirement: The operative note must document the clinical indication for biopsy, the scope type used, the anatomical location and number of biopsy sites, the biopsy technique, and the findings on visual inspection. Thin documentation is the top driver of 52204 denials.

What CPT Code 52204 Covers

CPT code 52204 is defined by the American Medical Association as “Cystourethroscopy, with biopsy(s).” It sits within the transurethral bladder and urethra surgical procedure family (codes 52204 through 52318) in the CPT code set. The procedure involves passing a cystoscope through the urethra to visually examine the bladder lining, urethra, prostatic urethra, and ureteric openings, then collecting one or more tissue specimens using cold cup biopsy forceps.

The “(s)” in the descriptor is the detail that causes the most billing confusion. It means the code covers every biopsy taken during the session, whether that is one specimen from a single suspicious lesion or multiple specimens from a four-quadrant bladder mapping. The specimen count drives the pathology bill, not the cystoscopy code. Practices report 52204 once per encounter with one unit of service, regardless of how many tissue samples are collected or how many separate containers they are sent in.

One question we hear constantly from urology practice managers is whether 52204 applies when the urologist biopsies a urethral lesion rather than a bladder lesion. The answer is yes. CPT 52204 covers biopsies of both bladder and urethral tissue obtained through the cystoscope. If the biopsy target is an isolated urethral site accessed without a cystoscope, that is a different code entirely (CPT 53200). The distinction turns on whether the scope went in, not on where the tissue came from.

What 52204 does not cover is fulguration, destruction, or resection of tissue. If the urologist cauterizes the biopsy site for hemostasis, that fulguration is included in 52204 and is not separately billable. However, if the encounter involves destroying or resecting a lesion rather than simply sampling it, the correct code shifts to the fulguration family (52214, 52224) or the tumor resection family (52234, 52235, 52240), depending on the lesion size and the documented procedure.

How 52204 and 52000 Bundling Works

This is the bundling rule that generates the most denials in cystoscopy billing, and it applies to every urology practice. CPT 52000 reports a diagnostic cystourethroscopy where nothing is biopsied, treated, or removed. The moment the urologist takes a biopsy during that same scope session, the encounter moves from diagnostic to surgical. CPT 52204 replaces 52000 entirely for that encounter.

Under the National Correct Coding Initiative (NCCI), 52000 is the Column Two code against 52204. When both codes appear on the same claim for the same date of service, payer edit software drops 52000 automatically before a human reviewer ever sees the claim. The result is a denied line item and a delayed payment cycle.

Across the billing companies we vet, this bundling error is one of the top five cystoscopy denial triggers for urology practices. The mistake usually stems from one of three scenarios: the coder treats the diagnostic look and the biopsy as two separate services, the operative note is structured in a way that makes them look sequential rather than part of one procedure, or the practice uses an EHR template that auto-populates both codes.

The rule also extends beyond 52000. CPT 52204 is a surgical endoscopy code, and surgical endoscopy always includes diagnostic endoscopy per CPT coding convention (General Endoscopy Guidelines, Section C.10 of the CPT codebook). So if the urologist scopes the bladder, identifies a suspicious area, and biopsies it, the entire encounter is 52204. For a deeper look at diagnostic cystoscopy billing and how the “separate procedure” designation works, see our full guide on CPT code 52000.

What Does CPT 52204 Pay in 2026?

Under the CY 2026 Medicare Physician Fee Schedule, CPT 52204 pays differently depending on where the procedure is performed. The distinction between facility and non-facility settings is the single biggest variable in the reimbursement, and it is the one most practices overlook when forecasting collections.

These are national rates before geographic adjustment. CMS applies Geographic Practice Cost Indices (GPCIs) by locality, which shift the actual payment. According to 2026 GPCI data, state-level averages range from approximately $313 in lower-cost states to over $409 in Alaska, a spread of about 31%. Commercial payer rates vary further and are set by negotiated contract, not by the fee schedule.

The 0-day global period is worth noting because it means there are no bundled postoperative visits. A follow-up E/M service on the same date is payable only when it meets the “significant and separately identifiable” standard and is reported with modifier 25. The decision to perform the cystoscopy with biopsy does not, by itself, qualify as a separately identifiable E/M service.

In our experience matching urology providers with billing partners, the gap between what a practice should collect on 52204 and what it actually collects often traces back to two problems: posting the payment without reading the remittance codes, and not reconciling payer payments against the contracted allowable. A billing partner that catches a $30 underpayment on every 52204 encounter across a busy surveillance caseload recovers real money over the course of a quarter.

What Documentation Does 52204 Require?

Documentation is where 52204 claims are won or lost. The operative note must tell the full story of why the biopsy was necessary and exactly what was done. Generic template language that reads like every other note in the chart is the fastest path to a payer records request or an audit flag.

A complete operative note supporting CPT 52204 documents the following elements:

• Clinical indication: The reason the biopsy was performed. Common supporting diagnoses include gross hematuria (ICD-10 R31.0), personal history of bladder malignancy under surveillance (Z85.51), carcinoma in situ of the bladder (D09.0), and abnormal findings on prior imaging. Isolated dysuria or urinary frequency without additional clinical findings rarely justifies a bladder biopsy on its own.
• Scope type: Whether a flexible or rigid cystoscope was used. While CPT 52204 does not differentiate between scope types, some commercial payers and Medicaid LCD policies require this documentation, and its absence can trigger a request for records.
• Findings on inspection: What the urologist saw before deciding to biopsy. The note should describe the appearance, size, and location of any lesion, mass, or area of concern. If random biopsies are taken from normal-appearing mucosa for surveillance, the note should state that explicitly.
• Biopsy details: The number of biopsy sites, the anatomical location of each, the technique used (cold cup forceps, not resection loop), and the number of specimens sent to pathology.
• Hemostasis: Whether cautery or fulguration was needed to control the biopsy site. This matters because it confirms the fulguration was incidental to the biopsy (included in 52204) rather than a separate therapeutic intervention (which would shift the code).

The biggest issue we see urology providers run into with 52204 documentation is a note that describes the biopsy but does not clearly establish why it was clinically indicated. A payer auditing the claim reads backward: they start with the code, check the diagnosis, and then look for the note to justify both. If the note says “biopsy taken” without connecting it to the presenting complaint or surveillance protocol, the claim is vulnerable.

Common ICD-10 Codes Paired with 52204

Medical necessity for CPT 52204 depends on a diagnosis that justifies why the urologist needed to biopsy tissue during the cystoscopy. The ICD-10 code must match the clinical scenario documented in the operative note, not a generic placeholder.

Providers often come to us after a string of 52204 denials, and when we help them look at the denied claims, the diagnosis code is frequently the culprit. Using R31.9 (unspecified hematuria) when the note clearly documents gross hematuria (R31.0) is a specificity failure that payers flag. Similarly, billing 52204 with a urinary tract infection diagnosis (N39.0) alone rarely meets medical necessity for a bladder biopsy unless the note documents additional clinical findings that warranted tissue sampling.

Modifiers Used with CPT 52204

Modifier use on 52204 is narrower than many practices assume. The code describes a single midline procedure (the bladder is one organ), so bilateral modifier 50 does not apply. The modifiers that do apply in specific, documented circumstances are:

• Modifier 25: Appended to the E/M code (not to 52204) when a significant, separately identifiable evaluation and management service is performed on the same date. The E/M must stand on its own clinical merit. A pre-procedure exam that simply confirms the plan to scope does not qualify.
• Modifier 59 (or XE/XS/XP/XU): Used in rare cases to indicate a distinct procedural service when 52204 is performed alongside another endoscopic procedure that would otherwise bundle. The operative note must clearly document distinct anatomical sites and separate diagnostic questions. Modifier 59 without supporting documentation pays today and gets recouped in post-payment review.
• Modifier 26 / TC: Used to split the professional and technical components when services are divided between the physician and a facility. The surgeon bills modifier 26 for the professional component; the facility bills the technical component with modifier TC.
• Modifier 76: Reported when the same physician repeats the procedure on the same day, such as when initial pathology findings require immediate additional sampling. Payers scrutinize these claims and typically request operative reports for both procedures.

One pattern we see across the billing companies we vet is modifier 59 being applied out of habit rather than clinical support. A practice that routinely appends modifier 59 to 52204 without distinct-site documentation is building an audit trail that will eventually be reviewed. The safer approach is to reserve the modifier for cases where the operative note genuinely supports a separate service.

Common CPT 52204 Denial Reasons and Fixes

Denials on 52204 follow predictable patterns. Identifying the pattern is the first step to fixing it, and fixing it at the documentation and coding level prevents the rework downstream.

1. Bundling denial (52000 + 52204 on the same claim). The most frequent 52204 denial. Fix: bill only 52204 when a biopsy is performed. Remove 52000 from the claim entirely.
2. Medical necessity failure. The ICD-10 code does not support a biopsy, or the diagnosis lacks specificity. Fix: use the most specific diagnosis code documented in the note (R31.0 over R31.9, Z85.51 for surveillance) and confirm the note establishes why biopsy was clinically indicated.
3. Documentation does not support the code. The operative note lacks biopsy site detail, technique, or clinical indication. Fix: build a documentation checklist into the pre-submission workflow that verifies the five elements listed in the documentation section above.
4. Modifier misuse. Modifier 59 appended without distinct-service documentation, or modifier 25 on an E/M that does not meet the separately identifiable threshold. Fix: review each modifier at the claim level against the operative note before submission.
5. Multiple units billed. Practice bills more than one unit of 52204 based on specimen count. Fix: 52204 is always one unit per session regardless of specimen count. The number of specimens affects the pathology codes, not the cystoscopy code.
6. Prior authorization missing. Some commercial payers require pre-procedure authorization for 52204 in ambulatory surgery center settings. Fix: verify authorization requirements for every payer before the procedure date, not after.

CPT 52204 vs Related Cystoscopy Codes

Several codes sit close to 52204 in the CPT codebook and get confused regularly. The operative note, not the intent of the encounter, determines which code is correct.

The critical distinction between 52204 and the 52224/52234 family is whether the urologist biopsied the tissue or destroyed/resected it. If the operative note describes fulguration or resection of a lesion as the primary intervention, that shifts the correct code away from 52204 even if a biopsy was also taken. The higher-level code includes the biopsy component. For the comparison between 52204 and diagnostic cystoscopy (52000), including the NCCI bundling rules, see our guide on CPT code 52000 billing and reimbursement.

How Pathology Is Billed Separately from 52204

A common point of confusion is whether CPT 52204 covers the pathology interpretation of the biopsy specimen. It does not. CPT 52204 covers the cystoscopy procedure and the physical act of collecting the tissue. The laboratory analysis and pathologist interpretation are reported separately under the surgical pathology codes (CPT 88302 through 88309), with the specific code determined by the specimen type and the level of examination required.

For a standard bladder biopsy, the pathology is typically reported under CPT 88305, which covers gross and microscopic examination of surgical pathology specimens at a defined complexity level. If the pathologist performs additional studies such as immunohistochemistry or special stains, those are reported with their own codes on top of the base pathology code.

This distinction matters for billing accuracy because the pathology codes are billed by the pathologist or the laboratory, not by the urologist who performed the cystoscopy. Practices that also own or operate an in-office pathology laboratory need to track both revenue streams and ensure each is coded independently.

CPT 52204 Billing Best Practices

Strong 52204 billing looks the same across well-run urology practices. These are the habits that keep the claim clean on first submission and prevent the rework that quietly drains staff time and delays collections.

• Bill 52204 once per encounter, one unit, every time. Specimen count does not change the unit count. Multiple biopsy sites, multiple containers, multiple pathology specimens: one unit of 52204.
• Never bill 52000 alongside 52204. The diagnostic cystoscopy is included. This is the single most preventable denial on this code.
• Match the ICD-10 to the note, not to the order. The diagnosis code must reflect what the operative note actually documents, not what the referring physician order says. If the note documents gross hematuria, code R31.0, not R31.9.
• Check NCCI edits quarterly. CMS updates NCCI edit tables on a regular cycle, and payers may apply their own bundling logic on top of the CMS edits. Verify the current edit status before submitting any code pair that could trigger a bundling denial.
• Build a pre-submission documentation checklist. Verify the five required note elements (indication, scope type, findings, biopsy details, hemostasis) before the claim goes out. Catching a documentation gap before submission is faster and cheaper than appealing a denial.
• Track denial patterns by payer. A practice that logs every 52204 denial by reason code and payer can spot trends early. If one payer starts denying for a specific reason, the fix is usually a documentation or coding adjustment, not an appeal.

In our experience matching providers with billing partners, the practices that collect the most on 52204 are not the ones performing the most procedures. They are the ones submitting the cleanest claims. A billing partner that audits every 52204 claim against the operative note before submission eliminates most of the denial and rework volume that bogs down in-house teams.

Frequently Asked Questions

Next Steps

• Need the diagnostic cystoscopy rules? Start with our full billing guide on CPT code 52000, which covers the NCCI bundling logic, the “separate procedure” designation, and 2026 reimbursement rates.
• Billing a urethral biopsy without a scope? Our guide to CPT code 53200 covers the code that applies when the biopsy is taken without cystoscopy.
• Moving from biopsy to resection? See our CPT 52601 TURP billing guide for how global periods and modifier rules change once the procedure becomes therapeutic.
• Ready to hand billing off? Get matched with vetted urology billing companies that catch bundling errors, underpayments, and documentation gaps before they cost your practice revenue.

CPT codes and descriptors are maintained by the American Medical Association, and ICD-10-CM is maintained by CMS and the NCHS. Both are provided here for reference. Payment amounts and conversion factors reflect the CY 2026 Medicare Physician Fee Schedule and change annually. Bundling, modifier, and global-period rules vary by payer and by Medicare contractor, so verify against current CPT and ICD-10-CM guidelines, the current NCCI edit file, the CMS PFS lookup tool for your locality, and payer policies before billing.